June 8, 2020 / 1:58 PM / 24 days ago

BRIEF-Sarepta Announces Positive Expression And Functional Data From SRP-9003 Gene Therapy Trial

June 8 (Reuters) - Sarepta Therapeutics Inc:

* SAREPTA THERAPEUTICS ANNOUNCES POSITIVE EXPRESSION AND FUNCTIONAL DATA FROM THE SRP-9003 GENE THERAPY TRIAL TO TREAT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2E

* SAREPTA THERAPEUTICS INC - A MEAN SIGNAL INTENSITY OF 73% IN HIGH-DOSE GROUP WAS OBSERVED COMPARED TO NORMAL CONTROL

* SAREPTA THERAPEUTICS INC - AN 89% MEAN REDUCTION OF CREATINE KINASE (CK) FROM BASELINE WAS OBSERVED IN HIGH-DOSE COHORT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below